V. Meraviglia

发表

Effects of smoking status, history and intensity on heart rate variability in the general population: The CHRIS study

G. Schmidt, P. Pramstaller, F. Murgia, 2019, PloS one.

Syngeneic Cardiac and Bone Marrow Stromal Cells Display Tissue-Specific microRNA Signatures and microRNA Subsets Restricted to Diverse Differentiation Processes

Rupesh K. Kesharwani, Mattia Chiesa, Luca Piacentini, 2013, PloS one.

In Vitro Epigenetic Reprogramming of Human Cardiac Mesenchymal Stromal Cells into Functionally Competent Cardiovascular Precursors

M. Capogrossi, C. Gaetano, V. Meraviglia, 2012, PloS one.

Human-iPSC-Derived Cardiac Stromal Cells Enhance Maturation in 3D Cardiac Microtissues and Reveal Non-cardiomyocyte Contributions to Heart Disease

C. Mummery, S. Semrau, A. Koster, 2020, Cell stem cell.

Exploring digenic inheritance in arrhythmogenic cardiomyopathy

F. S. Domingues, H. Blankenburg, P. Pramstaller, 2017, BMC Medical Genetics.

Metabolic Signature of Arrhythmogenic Cardiomyopathy

P. Pramstaller, G. Paglia, V. Meraviglia, 2021, Metabolites.

Are Requirements to Deposit Data in Research Repositories Compatible With the European Union's General Data Protection Regulation?

M. Wjst, L. Bygrave, K. Hveem, 2019, Annals of Internal Medicine.

The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) Restores Cardiomyocyte Contractility in a Rat Model of Early Diabetes

P. Pramstaller, V. Meraviglia, B. Motta, 2019, International journal of molecular sciences.

Toward Human Models of Cardiorenal Syndrome in vitro

C. Mummery, T. Rabelink, V. Meraviglia, 2022, Frontiers in Cardiovascular Medicine.

GCN5 contributes to intracellular lipid accumulation in human primary cardiac stromal cells from patients affected by Arrhythmogenic cardiomyopathy

P. Pramstaller, C. Tondo, S. Piazza, 2022, Journal of cellular and molecular medicine.

Human chorionic villus mesenchymal stromal cells reveal strong endothelial conversion properties.

M. Capogrossi, C. Gaetano, V. Meraviglia, 2012, Differentiation; research in biological diversity.

Generation of human induced pluripotent stem cell line LUMCi027-A and its isogenic gene-corrected line from a patient affected by arrhythmogenic cardiomyopathy and carrying the c.2013delC PKP2 mutation.

V. Meraviglia, C. Freund, M. Bellin, 2020, Stem cell research.

Generation of two human induced pluripotent stem cell lines, LUMCi020-A and LUMCi021-A, from two patients with Catecholaminergic Polymorphic Ventricular Tachycardia carrying heterozygous mutations in the RYR2 gene.

D. Atsma, C. Mummery, V. Meraviglia, 2020, Stem cell research.

Generation and characterization of three human induced pluripotent stem cell lines (EURACi007-A, EURACi008-A, EURACi009-A) from three different individuals of the same family with arrhythmogenic cardiomyopathy (ACM) carrying the plakophillin2 p.N346Lfs*12 mutation.

P. Pramstaller, V. Meraviglia, B. Motta, 2021, Stem cell research.

Derivation of human induced pluripotent stem cell line EURACi004-A from skin fibroblasts of a patient with Arrhythmogenic Cardiomyopathy carrying the heterozygous PKP2 mutation c.2569_3018del50

P. Pramstaller, V. Meraviglia, A. Rossini, 2018, Stem cell research.

Oxidized LDL‐dependent pathway as new pathogenic trigger in arrhythmogenic cardiomyopathy

D. Andreini, W. Birchmeier, A. Dello Russo, 2021, EMBO molecular medicine.

microRNAs and Cardiac Cell Fate

V. Meraviglia, A. Rossini, C. Piubelli, 2014, Cells.

Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids.

A. Hicks, P. Pramstaller, A. Lavdas, 2015, Journal of visualized experiments : JoVE.

Human mesenchymal stromal cells: how the tissue of origin influences plastic properties and microRNA expression profile

V. Meraviglia, Albert B. Einstein, V. Meraviglia, 2014 .

Higher cardiogenic potential of iPSCs derived from cardiac versus skin stromal cells.

L. Fassina, P. Pramstaller, C. Gaetano, 2016, Frontiers in bioscience.

Lipidomics, Atrial Conduction, and Body Mass Index.

Peter K. Joshi, H. Snieder, A. Teumer, 2019, Circulation. Genomic and precision medicine.

Inflammation in the Pathogenesis of Arrhythmogenic Cardiomyopathy: Secondary Event or Active Driver?

V. Meraviglia, M. Bellin, M. Alcalde, 2021, Frontiers in Cardiovascular Medicine.

Acetylation mediates Cx43 reduction caused by electrical stimulation.

P. Pramstaller, F. Recchia, M. Capogrossi, 2015, Journal of molecular and cellular cardiology.

The arrhythmogenic cardiomyopathy-specific coding and non-coding transcriptome in human cardiac stromal cells

F. S. Domingues, H. Blankenburg, P. Pramstaller, 2018, BMC Genomics.

Cardiac mesenchymal stromal cells are a source of adipocytes in arrhythmogenic cardiomyopathy

G. Pontone, A. Dello Russo, M. Capogrossi, 2015, European heart journal.

Desmosomal protein degradation as an underlying cause of arrhythmogenic cardiomyopathy

M. Mayr, C. Mummery, D. Versteeg, 2023, Science Translational Medicine.

Subchronic exposure to titanium dioxide nanoparticles modifies cardiac structure and performance in spontaneously hypertensive rats

E. Macchi, V. Meraviglia, A. Rossini, 2019, Particle and Fibre Toxicology.

Generation, functional analysis and applications of isogenic three-dimensional self-aggregating cardiac microtissues from human pluripotent stem cells

C. Mummery, V. Meraviglia, L. Yiangou, 2021, Nature Protocols.

HDAC Inhibition Improves the Sarcoendoplasmic Reticulum Ca2+-ATPase Activity in Cardiac Myocytes

F. S. Domingues, P. Pramstaller, C. Weichenberger, 2018, International journal of molecular sciences.

RagD auto-activating mutations impair MiT/TFE activity in kidney tubulopathy and cardiomyopathy syndrome

A. Ballabio, F. Trepiccione, V. Meraviglia, 2023, Nature communications.

Role of MicroRNAs in Arrhythmogenic Cardiomyopathy: translation as biomarkers into clinical practice.

R. Brugada, V. Meraviglia, M. Bellin, 2023, Translational research : the journal of laboratory and clinical medicine.

Modeling incomplete penetrance in arrhythmogenic cardiomyopathy by human induced pluripotent stem cell derived cardiomyocytes

P. Pramstaller, Eva König, V. Meraviglia, 2023, Computational and structural biotechnology journal.

Integrated Proteomics Unveils Nuclear PDE3A2 as a Regulator of Cardiac Myocyte Hypertrophy

M. Zaccolo, S. Mohammed, A. Scholten, 2023, Circulation research.

Vascularized hiPSC-derived 3D cardiac microtissue on chip

C. Mummery, V. Meraviglia, V. Orlova, 2023, Stem cell reports.

Generation of human induced pluripotent stem cell line EURACi006-A and its isogenic gene-corrected line EURACi006-A-1 from an arrhythmogenic cardiomyopathy patient carrying the c.1643delG PKP2 mutation.

V. Meraviglia, A. Rossini, C. Freund, 2021, Stem cell research.

Patient-specific primary and pluripotent stem cell-derived stromal cells recapitulate key aspects of arrhythmogenic cardiomyopathy

V. Meraviglia, M. Bellin, G. Pompilio, 2023, Scientific Reports.

The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) Restores Cardiomyocyte Contractility in a Rat Model of Early Diabetes

P. Pramstaller, V. Meraviglia, B. Motta, 2019, International journal of molecular sciences.

Generation of human induced pluripotent stem cells (EURACi001-A, EURACi002-A, EURACi003-A) from peripheral blood mononuclear cells of three patients carrying mutations in the CAV3 gene.

P. Pramstaller, V. Meraviglia, B. Motta, 2018, Stem cell research.